M Dowsett

No ORCID on file · 10 papers in corpus · active 1984-1995

Study types

  • article 7
  • letter 1
  • other 1
  • rct 1

Condition tags

  • endometriosis 10
  • dysmenorrhea 1
  • dyspareunia 1
article 1995
Clinical endocrinology ·doi:10.1111/j.1365-2265.1995.tb02926.x

OBJECTIVE: GnRH analogues are being used increasingly for a number of oestrogen dependent conditions in women. The resultant profound hypo-oestrogenism is a disadvantage, however, but the preservation of pituitary sensitivity to negative fe…

rct 1995
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57779-6

OBJECTIVE: To determine whether treatment of endometriosis with a GnRH analogue (GnRH-a; goserelin) combined with continuous estrogen and progestogen hormone replacement therapy (HRT) would prevent the hypoestrogenic effects, including loss…

article 1994
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a138788

The expression of receptors for the ovarian steroid hormones oestrogen and progesterone was studied immunohistochemically using monoclonal antibodies in samples of endometriosis and endometrium in 22 patients. In nine patients samples of en…

article 1991
Fertility and Sterility ·doi:10.1016/s0015-0282(16)54294-0
article 1990
Clinical endocrinology ·doi:10.1111/j.1365-2265.1990.tb03891.x

SUMMARY In an attempt to determine whether the suppression in oestradiol levels caused by danazol is due to an effect on the hypothalamic‐pituitary axis, we compared the endocrine effects of danazol with those of the LHRH (GnRH) agonist ana…

letter 1989
Lancet (London, England) ·doi:10.1016/s0140-6736(89)92659-7
other 1988
Fertility and Sterility ·doi:10.1016/s0015-0282(16)59706-4

Danazol and gestrinone are effective drugs in the treatment of endometriosis. Their mechanism of action remains uncertain, but may be related to their androgenic activity. The authors examined the effect of danazol on human endometrial cell…

article 1986
Clinical endocrinology ·doi:10.1111/j.1365-2265.1986.tb03285.x

Danazol and gestrinone are both effective agents in the treatment of endometriosis. Their mechanism of action is unknown but may be related to their androgenic activity, which is at least partly dependent on increases in the proportion of t…

article 1986
Clinical endocrinology ·doi:10.1111/j.1365-2265.1986.tb03614.x

Danazol is known to cause marked suppression of sex hormone binding globulin (SHBG) levels in plasma and to increase the proportion of plasma testosterone unbound to protein but the effect on the concentration of total and free testosterone…

article 1984
British journal of obstetrics and gynaecology ·doi:10.1111/j.1471-0528.1984.tb05901.x

The effects of danazol therapy on circulating gonadotrophins, oestradiol and sex hormone-binding globulin (SHBG) binding capacity have been studied in eight patients with endometriosis. There was a significant rise in luteinizing hormone (L…